Recent Updates
Recently added Catalysts

Varex Imaging Corporation

VREXFDA catalysts, PDUFA dates & pipeline intelligence
$18.1
▼ -0.03 · -0.17%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full VREX financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $6.7652W HIGH $14.57
Volume
1.24 M
Value Traded
22.50 M
Short % Float
4.87%
Days to Cover
3.2
+2.03%Week
-16.36%1 Month
-26.5%3 Month
-2.23%6 Month
-60.23%5 Year
-64.04%All Time

Cash Data

Unlock VREX cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
768.59 M
EPS (TTM)
-1.99
P/E Ratio
-
Ent. Value
730.55 M
Total Shares
41.89 M
Float Shares
41.73 M
Insiders
1.72%
Institutions
90.99%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
Unlock every VREX catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

VREX Catalyst Timeline

Dated clinical, regulatory and corporate events for Varex Imaging Corporation

Unlock the full VREX catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How VREX actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
No matching catalysts
Unlock all VREX historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

No drug pipeline

Varex Imaging Corporation is a medical device company. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.

Clinical Trial Results

Readouts, endpoints and source filings for every VREX program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Scroll for more · summaries link to the source press release
Unlock every VREX trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock VREX insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
Kunkel Jay K.DirectorSell -8,121 15,329 held$18.48 09/14/2026
Unlock the full VREX insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Fund % of Portfolio Current MV Shares Owned Activity
No hedge fund reported a 13F position in VREX for Q3 2026.
Unlock every fund holding VREX
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in VREX
Shares held by hedge funds each quarter, and who bought or sold.

Ownership Trends

Sign in to see VREX ownership
Insider and institutional ownership, quarter by quarter.

VREX Short Interest

Shares sold short, counted twice a month.

4.87%
Short % of Float
of tradable shares sold short
2.0M
Shares Sold Short
+24.7% vs prior count
3.2 Moderate
Days to Cover
trading days of normal volume to buy every short share back
639.7K
Avg Daily Volume
the average used for days to cover
Unlock VREX short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Option Volume

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
2026-11-20
Unlock VREX option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live VREX option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock VREX options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How VREX ranks across every disease it competes in

Competitive Position is a premium feature
See how VREX ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

VREX News

VREX
Oct 7, 2026
VREXGeneral

Varex Imaging and Waygate Technologies Announce Exclusive Partnership to Accelerate the Transformation of Field Radiography to Digital

Varex Imaging and Waygate Technologies have entered an exclusive partnership to advance the transformation of field radiography to digital formats. This collaboration is expected to enhance the efficiency and effectiveness of imaging technologies. The partnership signifies a strategic move towards modernizing radiographic practices.

Read more →
VREX
Sep 8, 2026
VREXGeneral

Varex Imaging Board of Directors Member, Dr. Jocelyn Chertoff wins RSNA Gold Medal

Dr. Jocelyn Chertoff, a member of Varex Imaging's Board of Directors, has been awarded the RSNA 2026 Gold Medal, the highest honor from the Radiological Society of North America. This award acknowledges her exceptional contributions to radiology, medical education, and imaging advancements. Varex Imaging expresses pride in her achievement and the benefits of her leadership.

Read more →
VREX
Aug 11, 2026
VREXConferences/Events

TrueSpectrum™ at Suzhou NDT Innovation Conference

Varex Imaging presented TrueSpectrum™ at the 7th Suzhou NDT Innovation Conference. Senior Application Specialist Jonathan Schock spoke to a full room about photon counting advantages. This method keeps photons at the detector for cleaner images and shorter scans. The company hosted a booth where attendees discussed the technology.

Read more →
VREX
Aug 10, 2026
VREXGeneral

Teledyne to Acquire Varex Imaging Corporation

Teledyne Technologies has announced its acquisition of Varex Imaging Corporation for $18.90 per share, valuing the deal at approximately $1.1 billion. The transaction, unanimously approved by both companies' boards, aims to enhance Teledyne's healthcare market presence and leverage Varex's advanced X-ray technologies. The acquisition is expected to close in early 2027, pending regulatory and stockholder approvals.

Read more →
VREX
Aug 10, 2026
VREXGeneral
▲ +48.8%on this newsshared move

Varex Announces Financial Results for Third Quarter Fiscal Year 2026

Varex Imaging Corporation reported its financial results for Q3 FY2026, with revenues of $211 million and a non-GAAP gross margin of 37%. The company experienced a year-over-year revenue increase of 4%, driven by strong growth in its Industrial segment. Notably, Varex recovered $17 million in tariffs, positively impacting its gross profit. However, the cancellation of the earnings conference call raises some investor concerns.

Read more →
VREX
Jul 7, 2026
VREXGeneral

White Paper: Pyxis™ Photon-Counting CT Detection Platform – Simplifying the Integration of Photon-Counting Computed Tomography

Varex Imaging's Pyxis™ platform enhances photon-counting CT (PCCT) technology, providing better spectral imaging and spatial resolution. The platform ensures diagnostic-grade performance by controlling detector linearity and spectral fidelity. This advancement aims to simplify the integration of PCCT in medical imaging.

Read more →
VREX
Jun 30, 2026
VREXGeneral
▲ +5.9%on this news

Replacing Mechanical Motion in X-ray Imaging: Varex Multi-Beam X-ray (MBX) Technology

Varex Imaging has launched its Multi-Beam X-ray (MBX) technology, revolutionizing X-ray generation by replacing mechanical motion with electronically controlled beams. This advancement allows for faster, more robust imaging systems and enhances image quality. The technology also supports new 3D imaging geometries, appealing to OEMs for next-generation performance.

Read more →
VREX
Jun 22, 2026
VREXConferences/Events

Tackling CT artifacts in multi-material parts: TrueSpectrum™ at ECNDT 2026

Varex Imaging presented its TrueSpectrum Imaging technology at ECNDT 2026, addressing the challenge of beam-hardening artifacts in multi-material parts. The method utilizes dual-energy acquisition on a photon-counting detector to enhance image quality without the need for physical filters. This approach improves both interior and exterior imaging from a single scan, increasing efficiency.

Read more →
VREX
May 28, 2026
VREXConferences/Events

Varex to Present at the Jefferies Global Healthcare Conference

Varex Imaging Corporation announced its participation in the Jefferies Global Healthcare Conference, scheduled for June 3, 2026. Management will engage in a fireside chat presentation at 3:10 pm ET, which will be available via webcast. This event highlights Varex's commitment to sharing insights and developments in the healthcare sector.

Read more →
VREX
May 18, 2026
VREXGeneral

The GigaCT: Advancing Photon-Counting CT for Next-Generation Spectral Imaging

Varex Imaging has launched the GigaCT, a photon-counting CT research system, in collaboration with the Technical University of Munich and Schleifring GmbH. This prototype aims to enhance spectral imaging by providing better spatial resolution and material differentiation. The system features advanced detector technology and a high-speed data architecture.

Read more →
VREX
May 7, 2026
VREXGeneral

Varex Announces Financial Results for Second Quarter Fiscal Year 2026

Varex Imaging Corporation has announced its financial results for the second quarter of fiscal year 2026. The report includes key financial metrics and performance indicators, although specific details are not provided in the text. This announcement is part of the company's ongoing financial disclosures.

Read more →
VREX
Apr 22, 2026
VREXConferences/Events

Varex Schedules Second Quarter Fiscal Year 2026 Earnings Release and Conference Call

Varex Imaging Corporation has announced the schedule for its second quarter fiscal year 2026 earnings release, which will take place on May 7, 2026. Following the release, a conference call will be held at 3:00 pm Mountain Time, accessible via webcast and phone. This event underscores Varex's commitment to transparency and investor communication.

Read more →
VREX
Mar 16, 2026
VREXGeneral

Varex Announces Successful Completion of Debt Refinancing

Varex Imaging Corporation has successfully completed a debt refinancing, entering into a new $490 million Credit Facility. This includes a secured term loan and revolving credit facility, aimed at strengthening the company's balance sheet. The refinancing is expected to reduce annual cash interest expenses significantly, enhancing financial flexibility for future investments.

Read more →
VREX
Jan 27, 2026
VREXConferences/Events

Varex Schedules First Quarter Fiscal Year 2026 Earnings Release and Conference Call

Varex Imaging Corporation has announced the schedule for its first quarter fiscal year 2026 earnings release, set for February 10, 2026. Following the release, a conference call will take place at 3:00 PM Mountain Time, which will be accessible via webcast. The call will also be available for replay for a limited time.

Read more →
VREX
Oct 18, 2017
VREXGeneral

Varex Imaging to Host Manufacturing Day Event for Local College and University Students

Varex Imaging Corporation is hosting a Manufacturing Day event on October 20th for over 40 college students. The event aims to change perceptions about manufacturing careers and will include facility tours, Q&A sessions with engineers, and a robotics demonstration. This initiative is in partnership with the University of Utah Manufacturing Extension Partnership.

Read more →
VREX
Jun 27, 2017
VREXConferences/Events

Varex Imaging to Participate in CJS Securities Investor Conference

Varex Imaging Corporation (Nasdaq: VREX) will participate in the CJS Securities 17th Annual New Ideas Summer Conference on July 11, 2017. CFO Clarence Verhoef will lead a fireside chat discussing the company's innovations and contributions to X-ray imaging. Varex is recognized for its extensive experience and range of imaging components.

Read more →
VREX
Feb 28, 2017
VREXConferences/Events

Varex Imaging to Exhibit Digital Imaging Components and Software Solutions at European Congress of Radiology

Varex Imaging will display digital imaging components and software at the European Congress of Radiology in Vienna from March 2 to 5. The exhibit features PaxScan DXV detectors, which consume half the power of previous generations, and the MCS 8064 CT replacement tube. These products highlight the company’s focus on low dose performance and lower life cycle costs for medical imaging systems.

Read more →
VREX
Feb 13, 2017
VREXConferences/Events

Varex Imaging to Participate in Two Upcoming Investor Conferences

Varex Imaging Corporation will participate in two upcoming investor conferences: the RBC Global Healthcare Conference on February 22, 2017, and the BTIG Fourth Annual Medical Technology, Life Sciences and Diagnostics Conference on March 1, 2017. CFO Clarence Verhoef will lead discussions at both events, providing insights into the company's operations. Webcast access will be available for investors.

Read more →

About Varex Imaging Corporation

Salt Lake City, UT 2,500 employees vareximaging.com
Headquarters1678 S. PIONEER ROAD, SALT LAKE CITY, UT, 84104
BIOPHARMAWATCH ELITE
Trade the next VREX catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $24/mo billed annually.
Cancel anytime